Study shows use of corticosteroid inhalers boosts risk of diabetes – Montreal Gazette

Study shows use of corticosteroid inhalers boosts risk of diabetes
Montreal Gazette
Inhaled steroids have become the mainstay of medical treatment of asthma and chronic obstructive pulmonary disease (COPD), the new name for emphysema and
Inhaled steroids may increase the risk of type 2 diabetesEndocrineWeb
Inhaled steroids increase diabetes risk, say Lady Davis Institute researchersEurekAlert (press release)

all 11 news articles »

View full post on asthma – Google News

Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma

Condition:   Asthma
Interventions:   Drug: FP 100mcg BID plus GSK2190915 100mg QD (AM);   Drug: FP 100mcg BID plus GSK2190915 300mg QD (AM);   Drug: FP 100mcg BID plus montelukast 10mg QD (PM);   Drug: FP 100mcg BID plus placebo BID;   Drug: FP/SAL 100/50mcg BID plus placebo BID
Sponsor:   GlaxoSmithKline
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days